1. Home
  2. PWOD vs SKYE Comparison

PWOD vs SKYE Comparison

Compare PWOD & SKYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PWOD
  • SKYE
  • Stock Information
  • Founded
  • PWOD 1934
  • SKYE 2012
  • Country
  • PWOD United States
  • SKYE United States
  • Employees
  • PWOD N/A
  • SKYE N/A
  • Industry
  • PWOD Major Banks
  • SKYE Biotechnology: Pharmaceutical Preparations
  • Sector
  • PWOD Finance
  • SKYE Health Care
  • Exchange
  • PWOD Nasdaq
  • SKYE Nasdaq
  • Market Cap
  • PWOD 173.1M
  • SKYE 172.9M
  • IPO Year
  • PWOD N/A
  • SKYE N/A
  • Fundamental
  • Price
  • PWOD $23.35
  • SKYE $3.01
  • Analyst Decision
  • PWOD
  • SKYE Strong Buy
  • Analyst Count
  • PWOD 0
  • SKYE 5
  • Target Price
  • PWOD N/A
  • SKYE $18.40
  • AVG Volume (30 Days)
  • PWOD 10.9K
  • SKYE 143.2K
  • Earning Date
  • PWOD 10-23-2024
  • SKYE 11-09-2024
  • Dividend Yield
  • PWOD 5.37%
  • SKYE N/A
  • EPS Growth
  • PWOD N/A
  • SKYE N/A
  • EPS
  • PWOD 2.31
  • SKYE N/A
  • Revenue
  • PWOD $64,822,000.00
  • SKYE N/A
  • Revenue This Year
  • PWOD N/A
  • SKYE N/A
  • Revenue Next Year
  • PWOD N/A
  • SKYE N/A
  • P/E Ratio
  • PWOD $9.71
  • SKYE N/A
  • Revenue Growth
  • PWOD N/A
  • SKYE N/A
  • 52 Week Low
  • PWOD $17.01
  • SKYE $1.44
  • 52 Week High
  • PWOD $24.10
  • SKYE $19.41
  • Technical
  • Relative Strength Index (RSI)
  • PWOD 62.90
  • SKYE 30.20
  • Support Level
  • PWOD $20.18
  • SKYE $5.03
  • Resistance Level
  • PWOD $23.90
  • SKYE $5.89
  • Average True Range (ATR)
  • PWOD 0.65
  • SKYE 0.59
  • MACD
  • PWOD 0.22
  • SKYE -0.22
  • Stochastic Oscillator
  • PWOD 91.40
  • SKYE 5.82

About PWOD Penns Woods Bancorp Inc.

Penns Woods Bancorp Inc is the bank holding company for Jersey Shore State Bank and Luzerne Bank. The banks serve customers in North Central and North Eastern Pennsylvania through their retail banking, commercial banking, mortgage services and financial services divisions. The Banks are engaged in commercial and retail banking which includes the acceptance of time, savings, and demand deposits, the funding of commercial, consumer, and mortgage loans, and safe deposit services. Utilizing a branch office network, ATMs, Internet, and telephone banking delivery channels, the Banks deliver their products and services to the communities residing in.

About SKYE Skye Bioscience Inc. Common Stock

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.

Share on Social Networks: